DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/1b3113/pharmaceutical_ind) has announced the addition of the "Pharmaceutical Industry in China 2011" report to their offering.
China has one of the world's top ten largest pharmaceutical markets. The pharmaceutical industry in China is a booming sector as it covers not only pharmaceutical drugs, but also synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China's pharmaceutical market has experienced significant growth in recent years, fueled by increasing wealth among its own population as well as the accelerating global demand for cheap, effective medicines to treat ailments ranging from high cholesterol to HIV/AIDS.
Yet, the country is plagued by worrying incidents, in some cases deadly ones, of poor drug quality. While these pharmaceutical production problems are not exclusive to China, they have tarnished its reputation abroad. Fears have been exacerbated by Beijing's failure to acknowledge quality shortcomings quickly. Most exports to wealthy industrialized countries which are monitored by pharmaceutical manufacturers policing their own supply chains and by strict drug regulatory authorities appear to be of high quality. However, data collected by European Union customs officials also show that China is among the world's top four exporters of counterfeit pharmaceuticals. Fears over intellectual property protection also plague the Chinese pharmaceutical industry.
However, with the sweeping reforms carried out by the Chinese government in a bid to ease international fears about its pharmaceutical and healthcare industries, the industry is undergoing significant change, as well as looking at major changes in the coming years. The increase of disposable income, the elevation of urbanization level and the country's aging population are all factors boosting China's pharmaceutical industry in the near future. With China being a major outsourcing hub for the global pharmaceutical industry, there is no doubt that the future of the Chinese pharmaceutical industry holds substantial growth potential as well.
Key Topics Covered:
- Executive Summary
- Industry Overview
- Market Analysis
- Regulatory Framework
- Industry Trends
- Industry Opportunities
- Research & Development in the Industry
- Clinical Trials in China
- Market for Active Pharmaceutical Ingredients (APIs)
- Vaccines Market in China
- China Pharmaceutical Industry: SWOT Analysis
- China Pharmaceutical Industry: PEST Analysis
- China Pharmaceutical Industry: Porter's Five Forces Analysis
- Generic Drug Sector in China
- Snapshot Profile: Biotechnology in China
- Snapshot Profile: Market for Traditional Chinese Medicine (TCM)
- Market for Medical Devices in China
- Competition in the Industry
- Major Industry Players
- China Pharmaceutical Industry: Industry Forecast
- Appendix
- Glossary
Companies Mentioned:
- China National Pharmaceutical Group Corporation (Sinopharm)
- China Greatvista Chemicals
- China Nepstar Chain Drugstore Ltd.
- China Shijiazhuang Pharmaceutical Group (CSPC)
- Harbin Pharmaceutical Group Co., Ltd.
- Hubei Biocause Pharmaceutical
- Jilin Aodong Medicine
- Nanjing Ange Pharmaceutical
- North China Pharmaceutical Corporation (NCPC)
- Shanghai Pharmaceutical
- Simcere Pharmaceutical
- WuXi PharmaTech
- Yunnan Baiyao Group
- AstraZeneca
- Bayer Schering Pharma
- Eli Lilly (Lilly China)
- GlaxoSmithKline Plc
- Merck & Co
- Merck KGaA
- Novartis
- Pfizer Inc.
- Roche
- Sanofi SA
For more information visit http://www.researchandmarkets.com/research/1b3113/pharmaceutical_ind